Texas Case Summaries
Federal Enforcement »

United States v. Williamson — Court denies compassionate release based on asthma and COVID-19 risk

Unreported / Non-Citable

Case
United States of America v. Jamaine Javon Williamson
Court
U.S. District Court for the Eastern District of Texas
Judge
Sean D. Jordan
Date Decided
November 18, 2021
Docket No.
4:19-CR-087-SDJ
Topics
Compassionate Release; COVID-19; Vaccination; Home Confinement

Background

Jamaine Javon Williamson was serving a 60-month prison sentence at FCI Herlong for possessing a firearm in furtherance of a drug-trafficking crime, in violation of 18 U.S.C. § 924(c). His anticipated release date was April 15, 2023.

Williamson asked the court to reduce his sentence to time served under 18 U.S.C. § 3582(c)(1)(A). He argued that his asthma, the COVID-19 pandemic, and his status as an African American created an extraordinary and compelling reason for release. He had first presented the same request to the prison warden, who denied it, so the parties agreed that he had satisfied the statute’s exhaustion requirement.

The Court’s Holding

The court denied compassionate release because Williamson had not shown an extraordinary and compelling reason for reducing his sentence. Although the Sentencing Commission’s policy statement in U.S.S.G. § 1B1.13 did not bind the court on a prisoner-filed motion, the court treated it as significant guidance and concluded that qualifying reasons should be similar in kind and scope to those identified by the Commission.

Williamson’s asthma was manageable with medication and did not presently prevent him from caring for himself in prison. His asserted harm instead depended on the future possibilities that he might contract COVID-19 and then suffer serious complications. The court also emphasized that Williamson had declined an available COVID-19 vaccine without identifying a medical contraindication or offering another explanation, making his elevated risk self-incurred rather than extraordinary and compelling.

To the extent Williamson alternatively sought home confinement, the court denied that request as well. It concluded that the Bureau of Prisons has exclusive authority to determine an inmate’s place of confinement and that the judiciary could not order his transfer to home confinement.

Key Takeaways

  • For prisoner-filed compassionate-release motions, U.S.S.G. § 1B1.13 was not binding under Fifth Circuit precedent, but the court used it as substantial guidance.
  • Manageable asthma and a possible future COVID-19 infection did not establish a present hardship sufficiently extraordinary and compelling to justify release.
  • An inmate’s unexplained refusal of an available COVID-19 vaccine weighed decisively against compassionate release based on the virus, and the court lacked authority to order home confinement.

Why It Matters

The decision illustrates how courts assessed COVID-19 compassionate-release motions after vaccines became available. A heightened medical risk, standing alone, may be insufficient when the condition is controlled, the claimed harm remains speculative, and the inmate declines vaccination without a compelling justification.

The opinion also distinguishes a judicial sentence reduction from placement in home confinement: even when a defendant asks for home confinement as alternative relief, that placement decision belongs to the Bureau of Prisons.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top